National Association of Testing Authorities, Australia
Scope of Accreditation
NSW Health Pathology
Site
NSW Health Pathology Royal North Shore Hospital Laboratory
Accreditation No.
1981
Site No.
1974
Date of Accreditation
06 Nov 1985
Address
Level 5 Main Building, Royal North Shore Hospital, 1 Reserve Road
St Leonards, NSW 2065
Australia
Contact
Ms Catherine Atkins P: +61 (02) 99264120
Availability
Services available to external clients
Supervision
GX (General)
Scope of Accreditation
NSW Health Pathology Royal North Shore Hospital Laboratory
ISO 15189 (2022)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Legal
Medicare expiry date
28 Feb 2027
Last Activity Date
05 Sep 2023
| Service | Product | Determinant |
|---|---|---|
| Medico legal drug testing AS/NZS 4308:2008, section 2 Specimen collection, storage, handling and dispatch | Urine | Colour; Creatinine; Temperature; pH |
Accident and Emergency Department
ISO 15189 (2022)
Human Pathology
Medicare expiry date
28 Feb 2027
Last Activity Date
05 Sep 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Bilirubin - Total; Calcium - Ionised; Carboxyhaemoglobin; Creatinine; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Burns Unit
ISO 15189 (2022)
Human Pathology
Medicare expiry date
28 Feb 2027
Last Activity Date
05 Sep 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Bilirubin - Total; Calcium - Ionised; Carboxyhaemoglobin; Creatinine; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Cardiac Catheter Laboratory
ISO 15189 (2022)
Human Pathology
Medicare expiry date
28 Feb 2027
Last Activity Date
05 Sep 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Bilirubin - Total; Calcium - Ionised; Carboxyhaemoglobin; Creatinine; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Delivery suite
ISO 15189 (2022)
Human Pathology
Medicare expiry date
28 Feb 2027
Last Activity Date
05 Sep 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Bilirubin - Total; Calcium - Ionised; Carboxyhaemoglobin; Creatinine; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Diabetes clinic
ISO 15189 (2022)
Human Pathology
Medicare expiry date
28 Feb 2027
Last Activity Date
05 Sep 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Glycated haemoglobin (HbA1c) |
Division of Anatomical Pathology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
28 Feb 2027
Last Activity Date
05 Sep 2023
| Service | Product | Determinant |
|---|---|---|
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations of body fluids, exudates, washings and brushings from non-squamous mucosal sites for the detection of malignancy | Cerebrospinal fluid (CSF); Other body fluids; Sputum; Urine; Washings or brushings from other sites | Cytological examination; Review and reporting of cytology samples |
| Anatomical pathology - Cytopathology - Non-gynaecological cytological investigations on samples obtained via fine needle aspiration biopsy | Fine needle aspirates (FNA) | Cytological examination; Review and reporting of fine needle aspiration samples |
| Anatomical pathology - Tissue pathology - Examination of biopsy material | Formalin-fixed tissue; Fresh tissue; Smears | Review and reporting of biopsy material to identify or exclude morphological abnormalities |
| Anatomical pathology - Tissue pathology - Gene probes using paraffin in situ hybridisation techniques (chromogenic/silver) | Formalin-fixed paraffin-embedded (FFPE) tissues | Detection of nucleic acid targets - Various |
| Anatomical pathology - Tissue pathology - Immediate frozen section diagnosis | Fresh tissue; Tissue imprint | Intra-operative consultation and examination of biopsy material |
| Anatomical pathology - Tissue pathology - Immunohistochemical investigation | Formalin-fixed paraffin-embedded (FFPE) tissues | Detection of antigenic targets - Various |
Division of Chemical Pathology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
28 Feb 2027
Last Activity Date
05 Sep 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Analysis of calculus | Renal calculi | Ammonium; Calcium; Carbonate; Cysteine; Magnesium; Oxalate; Phosphate; Urate |
| Chemical pathology - Analysis of drugs for toxicological (non-legal) purposes and ingested or absorbed toxic chemicals | Plasma; Serum | Ethanol |
| Chemical pathology - Detection and/or quantitation of drugs for therapeutic monitoring | Blood | Cyclosporin |
| Tacrolimus | ||
| Blood; Serum | Amikacin | |
| Plasma; Serum | Carbamazepine; Digoxin; Gentamicin (cidomycin, septopal, genticyn, garamycin); Lithium; Methotrexate; Paracetamol (acetaminophen); Phenobarbitone; Phenytoin (dilantin); Salicylate; Theophylline; Valproate (valproic acid, epilim); Vancomycin | |
| Chemical pathology - Detection and/or quantitation of tumour markers | Fine needle aspirates (FNA) | Thyroglobulin |
| Plasma; Serum | Human chorionic gonadotropin (hCG); Thyroglobulin | |
| Prostate specific antigen (PSA); Prostate specific antigen (PSA) fractions and derived index | ||
| CA125 antigen (CA125); CA15-3 antigen (CA15-3); CA19-9 antigen (CA19-9); Cancer associated serum antigen (CASA); Carcinoembryonic antigen (CEA); α-Fetoprotein (AFP) | ||
| Chemical pathology - Determination of hormones and hormone binding proteins (other than thyroid function tests) | Blood; Serum | Macroprolactin |
| Fine needle aspirates (FNA) | Parathyroid hormone (PTH) | |
| Calcitonin | ||
| Plasma | Adrenocorticotropic hormone (ACTH); Growth differentiation factor 15 (GDF15) | |
| Aldosterone; Fibroblast growth factor 23 (FGF23); Insulin-like growth factor 1 (IGF-1, somatomedin C); Renin | ||
| Plasma; Serum | Insulin | |
| Calcitonin; Growth hormone; Insulin-like growth factor-binding protein 3 (IGF-BP3) | ||
| C-peptide; Cortisol; Dehydroepiandrosterone sulfate (DHEAS); Follicle stimulating hormone (FSH); Insulin; Luteinising hormone (LH); Oestradiol; Parathyroid hormone (PTH); Procalcitonin; Progesterone; Prolactin; Sex hormone binding globulin (SHBG); Testosterone - Free; Testosterone - Total | ||
| 17α-Hydroxyprogesterone; Fibroblast growth factor 21 (FGF21) | ||
| Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Glycated haemoglobin (HbA1c) |
| Chemical pathology - Dynamic tests | Sweat | Sweat chloride |
| Chemical pathology - Further investigation of cardiac function | Plasma; Serum | Troponin |
| N-Terminal-pro b-type natriuretic peptide (NT-proBNP) | ||
| Troponin T | ||
| Chemical pathology - Further investigation of lipid profiles for diagnosis of types III and IV hyperlipidaemia | Other body fluids; Plasma; Serum | HDL - Quantitation |
| Chemical pathology - Further investigation of renal and/or hepatic function | Plasma; Serum | Bile acids - Quantitative; Caeruloplasmin; Haptoglobins; Prealbumin |
| Chemical pathology - Haem related pigments and precursors (excluding porphyria) | Cerebrospinal fluid (CSF) | Pigments in fluids; Xanthochromia |
| Plasma; Serum | Haptoglobins | |
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Cerebrospinal fluid (CSF) | Ammonia; Chloride; Glucose; Lactate; Lactate dehydrogenase (LDH); Protein - Total |
| Dialysates | Bicarbonate; Calcium - Total; Chloride; Creatinine; Glucose; Magnesium; Phosphate; Potassium; Sodium; Urea; Uric acid | |
| Drainage fluid | Cholesterol - Total | |
| Faeces | Chloride; Magnesium; Potassium; Sodium | |
| Chloride; Magnesium; Phosphate; Potassium; Sodium | ||
| Faeces; Other body fluids; Plasma; Serum; Urine | Osmolality | |
| Plasma; Serum | Alanine aminotransferase; Albumin; Alkaline phosphatase; Ammonia; Amylase; Aspartate aminotransferase; Bicarbonate; Bilirubin - Any fractions; Bilirubin - Total; C-reactive protein (CRP); Calcium - Corrected for albumin; Calcium - Total; Chloride; Cholesterol - Total; Cholinesterase; Creatine kinase; Creatinine; Glucose; Lactate; Lactate dehydrogenase (LDH); Lipase; Magnesium; Microalbumin; Phosphate; Potassium; Protein - Total; Sodium; Triglycerides; Urate; Urea; γ-Glutamyltransferase | |
| Pleural fluid | Albumin; Amylase; Bilirubin - Total; Cholesterol - Total; Glucose; Lactate dehydrogenase (LDH); Lipase; Protein - Total; Triglycerides; Uric acid | |
| Urine | Albumin; Ammonia; Amylase; Bicarbonate; Bilirubin - Any fractions; Bilirubin - Total; Calcium - Total; Chloride; Creatinine; Glucose; Magnesium; Microalbumin; Phosphate; Potassium; Protein - Total; Sodium; Urate; Urea | |
| Chemical pathology - Investigation for folate deficiency | Plasma; Serum | Folate |
| Chemical pathology - Investigation of maternal markers to detect foetal abnormality | Plasma; Serum | Free β-human chorionic gonadotropin (free β-hCG) |
| α-Fetoprotein (AFP) | ||
| Chemical pathology - Iron studies | Plasma; Serum | Ferritin; Iron; Transferrin; Transferrin - Iron saturation percentage (%) |
| Chemical pathology - Markers of bone metabolism | Plasma; Serum | Osteocalcin |
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Bilirubin - Total; Calcium - Ionised; Carboxyhaemoglobin; Creatinine; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
| Chemical pathology - Quantitation of precursor and intermediary metabolites | Plasma; Serum | Amino acids |
| Chemical pathology - Quantitation of vitamin B markers | Serum | Holotranscobalamin (active vitamin B12) |
| Chemical pathology - Quantitation of vitamins | Plasma; Serum | 1,25-Dihydroxyvitamin D |
| Cobalamin (vitamin B12) | ||
| 25-Hydroxyvitamin D | ||
| Chemical pathology - Tests for thyroid function | Plasma; Serum | Thyroid stimulating hormone (TSH); Thyroxine (T4) - Free; Triiodothyronine (T3) - Free |
| Chemical pathology - Trace element analysis | Blood; Other body fluids; Plasma; Serum; Urine | Aluminium; Antimony; Arsenic; Arsenic speciation; Barium; Beryllium; Bismuth; Boron; Cadmium; Chromium; Cobalt; Copper; Iodine; Iron; Lead; Lithium; Magnesium; Manganese; Mercury; Molybdenum; Nickel; Platinum; Selenium; Silver; Strontium; Tellurium; Thallium; Thorium; Tin; Titanium; Uranium; Vanadium; Zinc |
| Liver | Copper; Iron | |
| Urine | Beryllium | |
| Immunopathology - Detection and/or quantitation and/or characterisation of autoantibodies | Plasma; Serum | Anti-thyroglobulin antibodies (Tg); Anti-thyroid peroxidase antibodies (TPO) |
| Serum | Anti-glutamic acid decarboxylase 65 (GAD65); Anti-insulin antibodies; Anti-islet tyrosine phosphatase2 (IA2) antibodies | |
| Anti-thyrotropin receptor antibodies (TSHR) | ||
| Infertility and pregnancy tests including assisted reproductive technology - Diagnosis of pregnancy | Plasma; Serum | Human chorionic gonadotropin (hCG) |
| Infertility and pregnancy tests including assisted reproductive technology - Diagnosis or follow up of threatened abortion and/or diagnosis of ectopic pregnancy | Plasma; Serum | Human chorionic gonadotropin (hCG) - Quantitative total |
Division of Genetics
ISO 15189 (2022)
Human Pathology
Medicare expiry date
28 Feb 2027
Last Activity Date
05 Sep 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Investigation of malabsorption - Quantitation of solid tissue enzymes | Intestinal tissue | Lactase; Maltase; Sucrase; Trehalase |
| Chemical pathology - Investigation of maternal markers to detect foetal abnormality | Serum | α-Fetoprotein (AFP) |
| FMS-like tyrosine kinase 1 - Soluble; Free β-human chorionic gonadotropin (free β-hCG); Placental growth factor (PGF, PLGF); Pregnancy associated plasma protein A (PAPP-A) | ||
| Cytogenetics - Detection of defined, balanced and/or unbalanced chromosomal abnormalities by in situ hybridisation techniques | Blood; Bone marrow; Tissues | Cytogenetic analysis and reporting |
| Cytogenetics - Molecular karyotype (SNP microarray) detection of unbalanced chromosome abnormalities | Blood; Bone marrow; Tissues | Cytogenetic analysis and reporting |
| Molecular genetics - Assay for defined mutation or polymorphism (including pharmacogenetic testing) - Targeted genes | Amniotic fluid; Blood; Chorionic villus; Saliva | Apolipoprotein E; Factor V Leiden; Haemochromatosis; Lactase; Prothrombin gene (G20210A) mutation |
| Deafness | ||
| Blood | HLA-B27 | |
| Molecular genetics - DNA extraction | Amniotic fluid; Blood; Bone marrow; Chorionic villus tissue; Formalin-fixed paraffin-embedded (FFPE) tissues; Fresh tissue; Saliva | Viable DNA for sequencing and other molecular assays |
| Molecular genetics - DNA sequencing | Blood; Bone marrow; Formalin-fixed paraffin-embedded (FFPE) tissues | Sequenced DNA by Sanger sequencing; Sequenced DNA utilising massively parallel sequencing technologies |
| Molecular genetics - Estimation of risk of inheritance of an unknown mutation (Bayesian and linkage calculations) | Blood; Chorionic villus | Maternal cell contamination |
| Molecular genetics - Genetic testing for chimerism and mosaic gene variants (cancer and somatic mosaicism) - Targeted genes | Blood; Bone marrow | Isocitrate dehydrogenase IDH1 and IDH2 mutation analysis; KIT mutation analysis; Lymphoplasmacytic lymphoma; Nucleophosmin 1 (NPM1) mutation; Quantitative calculation of p190 and p210 positive BCR::ABL1 transcripts; Quantitative calculation of p210 positive BCR::ABL1 transcripts; Waldenstrom macroglobulinemia (WM) |
| Copy number variation (CNV) | ||
| JAK2 V617F mutation | ||
| Blood; Bone marrow; Cerebrospinal fluid (CSF); Formalin-fixed paraffin-embedded (FFPE) tissues; Fresh tissue; Tissues | B and T-cell gene rearrangement studies; Calreticulin; FLT3-ITD (internal tandem duplication) mutation; FLT3-TKD (tyrosine kinase domain) mutation; Myeloproliferative disorders; Nucleophosmin 1 (NPM1) mutation; Quantitation of donor and recipient bone marrow derived cells in a transplant recipient; Quantitative calculation of p190 positive BCR::ABL1; Quantitative calculation of p210 positive BCR::ABL1 transcripts; t(9;22) BCR-ABL gene rearrangement | |
| Blood; Bone marrow; Formalin-fixed paraffin-embedded (FFPE) tissues | Immunoglobulin (Ig) clonality analysis and minimal residual disease detection; Immunoglobulin heavy (IGH) somatic hypermutation; T-cell receptor (TCR) clonality analysis and minimal disease detection | |
| Formalin-fixed paraffin-embedded (FFPE) tissues | Solid tumours | |
| Molecular genetics - Heterozygous loci determinations | Blood; Saliva | Deafness panel |
| Molecular genetics - Screening for an unknown mutation - Targeted genes | Blood; Saliva | Deafness |
| Molecular genetics/Cytogenetics - Bioinformatic analysis | DNA sequences | Primary analysis - Conversion of instrument file to FASTQ or FASTA file; Secondary analysis - Alignment and variant calling; Tertiary analysis - Data annotation and interpretation |
Division of Haematology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
28 Feb 2027
Last Activity Date
05 Sep 2023
| Service | Product | Determinant |
|---|---|---|
| Haematology - Assessment of haemolysis or metabolic enzymes (red cell enzyme assays) | Blood | Glucose-6-phosphate dehydrogenase (G6PD) |
| Haematology - Bone marrow examination | Bone marrow | Examination of aspirated material |
| Haematology - Examination of blood films by special staining | Blood | Heinz bodies |
| Malaria | ||
| Haematology - Foetal haemoglobin in maternal circulation | Blood | Feto-maternal haemorrhage (FMH) estimation |
| Presence of foetal red blood cells | ||
| Haematology - Full blood examination | Blood | Morphology |
| Differential number; Erythrocyte count (red blood cell count, RBCC); Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Leucocyte count (white blood cell count, WBCC); Nucleated red blood cells (NRBC); Platelet count; Red blood cell distribution width (RDW); Red blood cell index or indices; Reticulocytes | ||
| Haematology - Haemostasis related analysis (including special coagulation testing and platelet function tests) | Blood | Platelet aggregation |
| Platelet function (PFA) | ||
| Plasma | Activated partial thromboplastin time (APTT); D-dimer; Fibrinogen; International normalised ratio (INR); Prothrombin time (PT); Thrombin time (TT) | |
| Anti-thrombin III; Lupus anticoagulant; Mixing studies - APTT; Protein C and protein S; Von Willebrand factor (vWF) antigen - Quantitation | ||
| Anti-Xa - Apixaban; Anti-Xa - Dabigatran; Anti-Xa - Rivaroxaban; Anti-Xa activity - Low molecular weight heparin; Anti-Xa activity - Unfractionated heparin | ||
| Platelet aggregation | ||
| Plasma; Serum | Heparin induced thrombotic thrombocytopenia (HITT); Von Willebrand factor (vWF) activity - Ristocetin co-factor assay | |
| Echis test; Factor II; Factor IX; Factor IX inhibitor; Factor V; Factor VII; Factor VIII; Factor VIII inhibitor; Factor X; Factor XI; Factor XII; Reptilase time; Von Willebrand factor (vWF) activity - Ristocetin co-factor assay | ||
| Haematology - Investigation of haemoglobinopathy (excluding thalassemia) | Blood; Plasma; Serum | Haemoglobin S (HbS) - Presence; Other abnormal haemoglobins |
| Haematology - Investigation of haemolysis | Urine | Haemoglobin (Hb); Haemosiderin |
| Haematology - Limited blood examination | Blood | Erythrocyte (RBC) sedimentation rate (ESR) |
| Immunohaematology - Blood group antibody detection | Blood; Plasma; Serum | Duffy system; Kell system; M and N factors; Other blood group systems; Rh phenotypes |
| Immunohaematology - Blood grouping | Blood | ABO; RhD |
| Immunohaematology - Determination of compatibility of blood donor units | Blood; Cord blood | Direct antiglobulin test (DAT, direct Coombs test); Examination for blood group antibodies; Group checks of patient and donor; Identification of detected antibodies |
| Immunohaematology - Identification and quantitation of blood group antibodies | Blood | Antibody elution |
| Antibody titration | ||
| Red blood cell phenotyping | ||
| Immunohaematology - Investigation of blood transfusion reactions | Blood; Blood products; Plasma | Antibodies; Contamination - Microbiological |
| Immunohaematology - Issue and release of blood and blood product for transfusion | Blood; Blood products; Cryoprecipitate; Fresh frozen plasma (FFP); Platelets | Issue and release of blood and blood products for transfusion |
| Immunohaematology - Storage and distribution of blood and blood components | Blood; Blood products; Cryoprecipitate; Fresh frozen plasma (FFP); Platelets | Issue and release of blood and blood products for transfusion |
| Immunopathology - Characterisation of leucocyte surface antigens (including immunophenotyping) | Blood; Bone marrow | CD3; CD34 |
| Blood; Bone marrow; Cerebrospinal fluid (CSF); Fresh tissue; Serous fluid | B2micro; CD10; CD103; CD105; CD117; CD11b; CD11c; CD123; CD13; CD138; CD14; CD15; CD16; CD185; CD19; CD197; CD1a; CD2; CD20; CD200; CD22; CD23; CD235a; CD24; CD25; CD26; CD27; CD279; CD28; CD3; CD30; CD300e (IREM-2); CD31; CD33; CD34; CD35; CD36; CD38; CD4; CD41; CD42b; CD43; CD45; CD45RA; CD45RO; CD49d; CD5; CD56; CD57; CD58; CD61; CD64; CD66c; CD7; CD71; CD79b; CD79αcy; CD8; CD81; CD9; CD94; CD95; CD99; Cytoplasmic CD3 (cyCD3); HLA-DR antigen; Immunoglobulin M (IgM); Kappa light chains; Lambda light chains; Myeloperoxidase; T-cell receptor γδ (TCRgd); Terminal deoxynucleotidyl transferase (TdT); cMPO; cyCD79a; cyGranzyme B; cyKappa; cyLambda; cyPerforin | |
| Immunopathology - Quantitative and/or qualitative investigation of proteins | Plasma; Serum | Cryofibrinogen |
| Microbiology - Parasitology - Detection of ova, cysts and parasites | Blood | Malaria |
Division of Immunopathology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
28 Feb 2027
Last Activity Date
05 Sep 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Detection and/or quantitation of tumour markers | Plasma; Serum | β2-Microglobulin (B2M) |
| Chemical pathology - Further investigation of renal and/or hepatic function | Plasma; Serum | α1-Antitrypsin |
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Cerebrospinal fluid (CSF) | Albumin |
| Immunopathology - Characterisation of leucocyte surface antigens (including immunophenotyping) | Blood | B-cell; Natural killer (NK) cells; T-cells |
| Immunopathology - Detection and/or quantitation and/or characterisation of autoantibodies | Plasma; Serum | Anti-intrinsic factor antibodies (IF) |
| Anti-extractable nuclear antigen antibodies (ENA) | ||
| Anti-adrenal cortex antibodies; Anti-aquaporin 4 antibodies (AQP4); Anti-endomysial antibodies (EMA); Anti-gastric parietal cell antibodies (GPC/PCA); Anti-islet cell antibodies (ICA); Anti-liver-kidney microsomes antibodies (LKM); Anti-mitochondrial antibodies (AMA, AMA M1 and/or AMA M2); Anti-neutrophil cytoplasmic antibodies (ANCA); Anti-nuclear antibodies (ANA); Anti-pemphigoid antibodies; Anti-pemphigus antibodies; Anti-skeletal muscle antibodies; Anti-smooth muscle antibodies (SMA) | ||
| Anti-extractable nuclear antigen antibodies (ENA) | ||
| Anti-chromatin antibodies | ||
| Anti-cyclic citrullinated peptide antibodies (CCP) | ||
| Serum | Rheumatoid factor | |
| Anti-double stranded DNA antibodies (dsDNA) | ||
| Tryptase | ||
| Anti-cardiolipin antibodies (ACA); Anti-deamidated gliadin antibodies; Anti-glomerular basement membrane antibodies (anti-GBM); Anti-myeloperoxidase antibodies (MPO); Anti-proteinase 3 antibodies (PR3); Anti-tissue transglutaminase antibodies (tTG); Anti-β2-glycoprotein-I antibodies | ||
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential component testing [purified native and/or recombinant allergens]) | Serum | Ara h2 - Peanut; Omega-5-gliadin - Wheat; Ovomucoid - Egg |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential drug allergens) | Serum | Amoxicilloyl group; Ampicilloyl group; Cefaclor; Chlorhexidine; Gelatin - Bovine; Morphine; Penicilloyl G; Penicilloyl V; Pholcodine |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential epidermal and animal protein allergens) | Serum | Animal mix; Cat dander; Cow dander; Dog dander; Horse dander |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [egg and fowl] allergens) | Serum | Chicken; Egg white; Egg yolk |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [fish, shellfish and molluscs] allergens) | Serum | Blue mussel; Codfish; Crab; Lobster; Octopus; Oyster; Salmon; Shrimp; Squid; Trout; Tuna |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [fruit and vegetable] allergens) | Serum | Apple; Avocado; Banana; Broccoli; Carrot; Celery; Garlic; Grape; Kiwi; Lettuce; Mango; Melon; Onion; Orange citrus; Pear; Pineapple; Potato; Strawberry; Tomato |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [meat] allergens) | Serum | Beef; Galactose-α-1,3-galactose; Mutton; Pork |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [milk] allergens) | Serum | Milk |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [miscellaneous] allergens) | Serum | Cacao; Hop (fruit cone); Mushroom; Staple food mix; Yeasts |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential food [seeds, legumes and nuts] allergens) | Serum | Almond; Barley; Brazil nut; Buck wheat; Cashew nut; Chick pea; Coconut; Gluten; Hazelnut; Lentil; Macadamia nut; Maize; Oat; Pea; Peanut; Pecan nut; Pinenut; Pistachio; Poppy seed; Rice; Rye; Sesame seed; Soy bean; Walnut; Wheat |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential grass pollen allergens) | Serum | Couch grass; Grass mix; Paspalum grass; Rye grass |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential insect allergens) | Serum | American cockroach; German cockroach; Oriental cockroach |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential microorganism allergens) | Serum | Alternaria alternata; Anisakis; Aspergillus fumigatus; Candida albicans; Cladosporium herbarum; Penicillium chrysogenum (formerly Penicillium notatum); Penicillium glabrum; Mould mix |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential mite allergens) | Serum | Blomia tropicalis house dust mite; Dermatophagoides farinae house dust mite; Dermatophagoides microceras house dust mite; Dermatophagoides pteronyssinus house dust mite; Euroglyphus mayne house dust mite |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential occupational allergens) | Serum | House dust; Latex; Sunflower seed |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential tree pollen allergens) | Serum | Acacia; Cypress; Eucalyptus; London plane; Olive; Privet; Silver birch |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential venom allergens) | Serum | Bee venom; Common wasp (yellow jacket) venom; Paper wasp venom |
| Immunopathology - Detection of immunoglobulin E specific antibodies (to potential weed pollen allergens) | Serum | Plantain - English; Wall pellitory |
| Immunopathology - Quantitation of complement proteins | Plasma; Serum | Complement components C3 and C4 |
| Immunopathology - Quantitative and/or qualitative investigation of proteins | Cerebrospinal fluid (CSF) | Oligoclonal bands |
| Plasma; Serum; Urine | Albumin; Detection of Bence Jones proteins; α1-Globulin; α2-Globulin; β-Globulin; γ-Globulin | |
| Serum | Detection and quantitation of free kappa and free lambda light chains | |
| Cryoglobulins | ||
| Immunopathology - Quantitative investigations of immunoglobulins and immunoglobulins subclasses | Cerebrospinal fluid (CSF) | Total immunoglobulin G |
| Plasma; Serum | Total immunoglobulin A; Total immunoglobulin G; Total immunoglobulin M | |
| Total immunoglobulin E | ||
| Serum | Immunoglobulin G (IgG) subclasses; Immunoglobulin subclasses | |
| Immunopathology - Single HLA antigen typing | Blood | HLA-B5801 |
| Microbiology - Bacteriology - Detection and identification of crystalline material | Synovial fluid | Crystal detection and identification |
| Microbiology - Bacteriology - Detection of pathogenic bacteria | Synovial fluid | Leucocytes (white blood cells, WBC) |
| Microbiology - Molecular biology - Quantitation of microbial nucleic acids | Plasma; Serum | Human immunodeficiency virus (HIV) RNA viral load |
| Microbiology - Mycobacteriology - Tests for antigen lymphocyte stimulation | Blood | Mycobacterial antigen lymphocyte stimulation |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Plasma; Serum | Human immunodeficiency virus type 1/2 (HIV-1/2) 1/2 antibodies; Human immunodeficiency virus type 1/2 (HIV-1/2) antigen |
| Avian precipitins (bird fancier's disease) | ||
| Human immunodeficiency virus (HIV) | ||
| Aspergillus-specific IgG | ||
| Serum | Human immunodeficiency virus type 1/2 (HIV-1/2) antigen | |
| Human T-lymphotropic virus type I/II (HTLV-I/II) |
Division of Microbiology
ISO 15189 (2022)
Human Pathology
Medicare expiry date
28 Feb 2027
Last Activity Date
05 Sep 2023
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Bacteriology - Detection of pathogenic bacteria | Aspirates; Blood; Cerebrospinal fluid (CSF); General swabs; Respiratory specimens; Sputum; Tissues; Urethra | Pathogenic identification and antibiotic susceptibility |
| Bacterial isolates | Pathogenic identification and antibiotic susceptibility | |
| Faeces | Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC); Pathogenic identification and antibiotic susceptibility | |
| Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC); Pathogenic identification and antibiotic susceptibility | ||
| Clostridioides difficile toxin | ||
| Urine | Bilirubin; Blood; Epithelial cells; Erythrocytes (red blood cells, RBC); Glucose; Ketones; Leucocyte esterase; Leucocytes (white blood cells, WBC); Nitrite; Proteins; Specific gravity; Urobilinogen; pH | |
| Bacteria; Casts; Epithelial cells; Erythrocytes (red blood cells, RBC); Leucocytes (white blood cells, WBC); Pathogenic identification and antibiotic susceptibility | ||
| Streptococcus pneumoniae | ||
| Legionella pneumophila | ||
| Microbiology - Environmental investigations and/or infection control (Clinical non-human testing) | Blood transfusion bags; Bronchoscopes; Environmental swabs; Gastrointestinal endoscopes; Vascular catheter tips | Bacterial growth - Sterility; Bacterial organism identification - Acinetobacter; Bacterial organism identification - Carbapenem resistant Enterobacteriaceae (CRE); Bacterial organism identification - Extended spectrum β-lactamases (ESBL); Bacterial organism identification - Metallo-β-lactamase (MBL) carbapenemase; Bacterial organism identification - Methicillin-resistant Staphylococcus aureus (MRSA); Bacterial organism identification - Vancomycin-resistant Enterococcus (VRE) |
| Dialysis waters | Bacterial growth - Sterility | |
| Environmental swabs | Mycology identification | |
| Spore strips | Bacterial growth - Sterility | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) | Bacterial isolates | Van A/B |
| Bacterial isolates; Blood | Carbapenem resistant Enterobacteriaceae (CRE); MecA gene | |
| Bacterial isolates; Blood; Dry swabs; Tissues | Pan-bacterial 16s | |
| Blood; Dry swabs; Tissues | Borrelia burgdorferi | |
| Rickettsia rickettsii | ||
| Blood; General swabs | Borrelia spp.; Rickettsia spp. | |
| Cerebrospinal fluid (CSF) | Neisseria meningitidis; Streptococcus pneumoniae | |
| Faeces | Campylobacter spp.; Clostridioides difficile; Salmonella spp.; Shigella spp.; Yersinia spp. | |
| Clostridioides difficile | ||
| Genital swabs; Liquid based cytology specimens; Rectal swabs; Throat swabs; Urine | Neisseria gonorrhoeae | |
| Genital swabs; Liquid based cytology specimens; Urine | Chlamydia trachomatis; Neisseria gonorrhoeae | |
| Genital swabs; Rectal swabs; Throat swabs; Urine | Mycoplasma genitalium; Neisseria gonorrhoeae; Fluoroquinolone resistant Neisseria gonorrhoeae; Macrolide resistant Mycoplasma genitalium | |
| Rectal swabs; Throat swabs; Urethral swabs | Chlamydia trachomatis; Neisseria gonorrhoeae | |
| Respiratory specimens | Bordetella pertussis; Chlamydophila pneumoniae; Chlamydophila psittaci; Legionella longbeachae; Legionella pneumophila; Mycoplasma pneumoniae | |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (fungi) | Respiratory specimens | Pneumocystis jirovecii |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (mycobacteria) | Respiratory specimens; Tissues; Urine | Mycobacterium tuberculosis |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (protozoan parasites) | Faeces | Blastocystis spp.; Cryptosporidium spp.; Dientamoeba fragilis; Giardia spp. |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Bronchial washings; Nasopharyngeal aspirate | Influenza A virus; Influenza B virus; Respiratory syncytial virus (RSV) |
| Bronchial washings; Nasopharyngeal aspirate; Nasopharyngeal swabs; Throat swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | ||
| Bronchoalveolar lavage; Endotrachael aspirate; Nasal swabs; Nasopharyngeal aspirate; Nasopharyngeal swabs; Sputum; Throat swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | ||
| Cerebrospinal fluid (CSF) | Enterovirus; Herpes simplex virus type 1 (HSV1); Herpes simplex virus type 2 (HSV2); Human parechovirus; Varicella zoster virus (VZV) | |
| Cerebrospinal fluid (CSF); Eye swabs; Genital swabs; Mouth swabs; Ocular fluid; Rectal swabs; Skin swabs; Throat swabs; Tissues; Vesicle swabs; Vitreous specimens | Adenovirus; Cytomegalovirus (CMV); Enterovirus; Herpes simplex virus type 1 (HSV1); Herpes simplex virus type 2 (HSV2); Varicella zoster virus (VZV) | |
| Dry swabs; Nasopharyngeal aspirate | Influenza A virus; Influenza B virus; Respiratory syncytial virus (RSV) | |
| Faeces | Adenovirus; Norovirus G1; Norovirus G2; Rotavirus | |
| Nasal aspirates/washes; Nasal swabs; Nasopharyngeal swabs; Throat swabs | Influenza A virus; Influenza B virus; Respiratory syncytial virus (RSV); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Nasal swabs; Nasopharyngeal swabs; Throat swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Plasma | Cytomegalovirus (CMV) | |
| Hepatitis C virus (HCV) genotypes 1-6 and subtypes | ||
| Plasma; Serum | Hepatitis B virus (HBV) DNA; Hepatitis C virus (HCV) viral load | |
| Respiratory specimens | Adenovirus; Coronavirus; Enterovirus; Human metapneumovirus; Human parechovirus; Influenza A virus; Influenza B virus; Influenza virus H1/H3; Parainfluenza virus type 1/2/3/4; Rhinovirus; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Microbiology - Mycobacteriology - Detection and identification of mycobacteria | Blood; Bone marrow; Bronchoalveolar lavage; Cerebrospinal fluid (CSF); Faeces; Gastrointestinal fluid; Isolates; Lymph node fluid; Respiratory specimens; Skin swabs; Sputum; Tissues; Urine | Mycobacteria identification |
| Microbiology - Mycology - Detection of dermatophytes and other fungi causing cutaneous disease | Hair; Nails; Skin scrapings | Dermatophyte identification |
| Microbiology - Mycology - Detection, isolation and/or identification of yeasts and/or fungal elements | Aspirates; Blood; Bronchial lavage; Cerebrospinal fluid (CSF); Fine needle aspirates (FNA); Fluids; Genital swabs; Peritoneal fluid; Pleural fluid; Pus; Respiratory specimens; Skin swabs; Sputum; Synovial fluid; Throat swabs; Tissues; Urine; Wound swabs | Fungi identification; Yeasts identification |
| Isolates | Fungi susceptibility | |
| Fungi identification; Fungi susceptibility; Yeast susceptibility; Yeasts identification | ||
| Isolates; Skin | Fungi identification; Fungi susceptibility; Yeast susceptibility; Yeasts identification | |
| Microbiology - Parasitology - Detection of ova, cysts and parasites | Faeces | Cysts; Ova; Parasites |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Serum | Syphilis Treponema pallidum antibody |
| Cytomegalovirus antibody (anti-CMV) IgG; Cytomegalovirus antibody (anti-CMV) IgM; Epstein-Barr virus nuclear antigen IgG antibody; Epstein-Barr virus viral capsid antigen IgG antibody; Epstein-Barr virus viral capsid antigen IgM antibody; Hepatitis A virus antibody (anti-HAV) - IgG; Hepatitis A virus antibody (anti-HAV) - IgM; Hepatitis B virus core antibody (anti-HBc) - Total; Hepatitis B virus envelope antibody (anti-HBe); Hepatitis B virus envelope antigen (HBe Ag); Hepatitis B virus surface antibody (anti-HBs); Hepatitis B virus surface antigen (HBs Ag); Hepatitis B virus surface antigen (HBs Ag) - Quantitative; Hepatitis C virus antibody (anti-HCV); Rubella IgG antibody; Rubella IgM antibody; Syphilis Treponema pallidum antibody; Toxoplasma spp. IgG antibody; Toxoplasma spp. IgM antibody | ||
| Legionella longbeachae; Legionella pneumophila serogroup 1 antibody | ||
| Streptococcal anti-DNAse B (anti-streptodornase) antibody | ||
| Echinococcus spp.; Entamoeba histolytica | ||
| Borrelia burgdorferi; Helicobacter pylori; Herpes simplex virus (HSV) IgM; Herpes simplex virus type 2 antibody (anti-HSV2) - IgG; Herpes simplex type 1 antibody (anti-HSV1) - IgG; Measles IgG antibody; Measles IgM antibody; Mumps virus IgG antibody; Mumps virus IgM antibody; Mycoplasma IgM antibody; Parvovirus IgG antibody; Parvovirus IgM antibody; Varicella zoster virus (VZV) IgG antibody; Varicella zoster virus IgM antibody | ||
| Mycoplasma total antibody | ||
| Borrelia burgdorferi | ||
| Hepatitis C virus antibody (anti-HCV) | ||
| Dengue virus IgG antibody; Dengue virus IgM antibody; Dengue virus NS1 antigen | ||
| Syphilis Treponema pallidum antibody | ||
| Cryptococcus spp. | ||
| Cryptococcus spp. | ||
| Anti-streptolysin O (ASOT) | ||
| Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) IgG antibody | ||
| Borrelia burgdorferi | ||
| Microbiology - Virology - Detection of pathogenic viruses | Faeces | Adenovirus; Rotavirus |
Intensive Care Unit
ISO 15189 (2022)
Human Pathology
Medicare expiry date
28 Feb 2027
Last Activity Date
05 Sep 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Base excess; Bicarbonate; Calcium - Ionised; Carboxyhaemoglobin; Chloride; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxygen saturation (sO2); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Intensive Care Unit (North Shore Private Hospital)
ISO 15189 (2022)
Human Pathology
Medicare expiry date
28 Feb 2027
Last Activity Date
05 Sep 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Bilirubin - Total; Calcium - Ionised; Carboxyhaemoglobin; Creatinine; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Intensive Therapy Unit
ISO 15189 (2022)
Human Pathology
Medicare expiry date
28 Feb 2027
Last Activity Date
05 Sep 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Bilirubin - Total; Calcium - Ionised; Carboxyhaemoglobin; Creatinine; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Maternity ward
ISO 15189 (2022)
Human Pathology
Medicare expiry date
28 Feb 2027
Last Activity Date
05 Sep 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Bicarbonate; Bilirubin - Total; Calcium - Ionised; Carboxyhaemoglobin; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Neonatal Intensive Care Unit
ISO 15189 (2022)
Human Pathology
Medicare expiry date
28 Feb 2027
Last Activity Date
05 Sep 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Bilirubin - Total; Calcium - Ionised; Carboxyhaemoglobin; Creatinine; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Paed diabetic clinic
ISO 15189 (2022)
Human Pathology
Medicare expiry date
28 Feb 2027
Last Activity Date
05 Sep 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Glycated haemoglobin (HbA1c) |
Special Care Nursery (North Shore Private Hospital)
ISO 15189 (2022)
Human Pathology
Medicare expiry date
28 Feb 2027
Last Activity Date
05 Sep 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Calcium - Ionised; Chloride; Glucose; Haematocrit (packed cell volume, PCV); Haemoglobin (Hb); Lactate; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Theatres
ISO 15189 (2022)
Human Pathology
Medicare expiry date
28 Feb 2027
Last Activity Date
05 Sep 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Bilirubin - Total; Calcium - Ionised; Carboxyhaemoglobin; Creatinine; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
Theatres (North Shore Private Hospital)
ISO 15189 (2022)
Human Pathology
Medicare expiry date
28 Feb 2027
Last Activity Date
05 Sep 2023
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Quantitation of blood gases and other measurements (performed on the same specimen) | Blood | Bilirubin - Total; Calcium - Ionised; Carboxyhaemoglobin; Creatinine; Glucose; Haemoglobin (Hb); Lactate; Methaemoglobin (MetHb); Oxyhaemoglobin; Partial pressure of carbon dioxide (pCO2); Partial pressure of oxygen (PO2); Potassium; Sodium; pH |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
1981
Site No.
1974
Print date
28 Nov 2024
END OF SCOPE